Richard Fuhrherr

Title: Richard Fuhrherr: Innovator in Pharmaceutical Compositions

Introduction

Richard Fuhrherr is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions involving oligosaccharides. With a total of 3 patents to his name, Fuhrherr continues to push the boundaries of pharmaceutical science.

Latest Patents

Fuhrherr's latest patents include groundbreaking work on powders comprising new compositions of oligosaccharides and methods for their preparation. One of his inventions concerns powders that contain a pharmaceutical active substance combined with excipients, including at least one 1,4 O-linked saccharose derivative. This derivative can be selected from compounds such as 1,4 O-linked D-Gal-saccharose (lactosucrose), 1,4 O-linked D-Glu-saccharose (glucosyl sucrose), or 1,4 O-linked Glu-Glu-saccharose (maltosyl sucrose). The invention also emphasizes the inclusion of additional excipients, which may be amino acids, peptides, or other saccharide derivatives.

Another significant patent involves a spray-dried powder that contains a pharmaceutical active substance along with one or more 1,4 O-linked saccharose derivatives. This method of manufacture is designed to enhance the efficacy and stability of the pharmaceutical compositions.

Career Highlights

Richard Fuhrherr is currently employed at Boehringer Ingelheim Pharma GmbH & Co. KG, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the company's research and development efforts in the pharmaceutical sector.

Collaborations

Fuhrherr collaborates with talented professionals in his field, including colleagues such as Stefan Bassarab and Karoline Bechtold-Peters. These collaborations foster a creative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Richard Fuhrherr is a distinguished inventor whose work in pharmaceutical compositions has led to significant advancements in the industry. His innovative patents and collaborations continue to shape the future of pharmaceutical science.